Skip to content
Search

Latest Stories

England's test and trace system reaches 26,985 in first week

England's new track and tracing system was able to contact two thirds of the people who tested positive for Covid-19 and were referred to it in its first week, and then succeeded in contacting 85 per cent of their contacts to ask them to self isolate.

Of the 8,117 who were transferred to the system, 2,710 were not reached and did not provide details of their recent contacts, illustrating the challenge faced by a programme which is seen as a key tool to help loosen blanket lockdown measures.


A smartphone tracking app will be added to the programme in coming weeks, although the government has not specified when.

Releasing its first data, the Department of Health's test and trace programme said it reached 31,794 contacts of the original positive cases between 28 May and 3 June, and of those it was able to reach 26,985, or 85 per cent, and advise them to self-isolate.

Each person who tested positive and was traced had the equivalent of 5.9 contacts per person.

Meanwhile, Moderna Inc on Thursday (June 11) confirmed it plans to start a trial of 30,000 volunteers of its much-anticipated coronavirus vaccine in July as the company enters the final stage of testing.

The Cambridge, Massachusetts-based biotech said the primary goal of the study would be to prevent symptomatic Covid-19, the disease caused by the novel coronavirus. The key secondary goal would be prevention of severe disease, as defined by keeping people out of the hospital.

Moderna said it has selected the 100 microgram dose of the vaccine for the late-stage study. At that dose level, the company is on track to deliver about 500 million doses per year, and possibly up to one billion doses per year, starting in 2021 from the company's internal US manufacturing site and strategic collaboration with Swiss drugmaker Lonza.

(Reuters)

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less